During Nordic Life Science Days 2022 in Malmö, several interesting panel discussions were arranged with prominent people in various fields. One of the discussions concerned deep tech, an umbrella term including technology that is based on combined breakthroughs of both scientists and engineers addressing society problems. BioStock got the opportunity to talk to two of the speakers – Armend G. Håti from ClexBio and David Sonnek from Navigare Ventures.
Navigare Ventures is an investment company within Wallenberg Investments specialized in deep tech companies. See the interview with the company’s CEO David Sonnek below.
ClexBio is a Norwegian biotech company developing next-generation tissue engineering and single-cell technology. See the interview with the company’s CEO Armend G.Håti below.